Protagonist Therapeutics Inc

-

Stock Issuer and Owners

Home | Sign Up | Log In
List of Funds
Boston Firms
Boston Hedge Funds
Cornell Alumni Firms
CalPERS Portfolio
NYSCRF Portfolio
Latest Filings
User Guide
Regulatory AUM vs AUM
LP Portfolios
Related Firms
Build a Portfolio
Comprehensive Search
Protagonist Therapeutics Inc
TickerPTGX
CIK #0001377121
CUSIP74366E102
SectorLife Sciences - Pharmaceutical Preparations
Address521 Cottonwood Drive, Suite 100, Malpitas, CA 95035-7404
Source [EDGAR]
CIK Filing 2011 - 2024
[0001377121] 10-K
[0001377121] 10-Q
[0001377121] 3
[0001377121] 4
[0001377121] 8-K
[0001377121] D
[0001377121] SC 13D
[0001377121] SC 13G
Form 13D/13G Filer Form 13D/13G Subject Filed % Owned
Adage Capital Partners GP LLC Protagonist Therapeutics Inc [2023-04-13] 5.44
Biotechnology Value Fund L P Protagonist Therapeutics Inc [2023-03-20] 5.1
Vanguard Group Inc Protagonist Therapeutics Inc [2023-02-09] 6.3
Citadel Advisors LLC Protagonist Therapeutics Inc [2023-01-03] 3.6
State Street Corp Protagonist Therapeutics Inc [2022-02-10] 5.39
Point72 Asset Management LP Protagonist Therapeutics Inc [2021-09-21] 0.1
Consonance Capital Management LP Protagonist Therapeutics Inc [2021-02-17] 5.75
Consonance Capital Management LP Protagonist Therapeutics Inc [2021-02-16] 5.75
BlackRock Inc Protagonist Therapeutics Inc [2021-02-02] 6.2
Adage Capital Partners GP LLC Protagonist Therapeutics Inc [2020-05-22] 6.39
BlackRock Inc Protagonist Therapeutics Inc [2020-02-07] 5.7
RTW Investments LP Protagonist Therapeutics Inc [2019-12-16] 8.04
Integrated Core Strategies US LLC Protagonist Therapeutics Inc [2019-07-01] 3.5
Venrock Healthcare Capital Partners II LP Protagonist Therapeutics Inc [2019-06-17] 6.4
Perceptive Advisors LLC Protagonist Therapeutics Inc [2018-12-10] 5.3
Farallon Capital Management LLC Protagonist Therapeutics Inc [2018-08-20] 1.9
Great Point Partners LLC Protagonist Therapeutics Inc [2018-07-02] 6.95
Biotechnology Value Fund L P Protagonist Therapeutics Inc [2018-05-24] 3.4
FMR LLC Protagonist Therapeutics Inc [2016-10-11] 0.0
Aisling Capital IV LP Protagonist Therapeutics Inc [2016-09-12] 5.1
Lilly Ventures Fund I LLC Protagonist Therapeutics Inc [2016-08-26] 12.9
RA Capital Management LLC Protagonist Therapeutics Inc [2016-08-25] 6.8
Adage Capital Partners GP LLC Protagonist Therapeutics Inc [2016-08-19] 0.69
Johnson & Johnson Protagonist Therapeutics Inc [2016-08-19] 15.0
Form 3/4/5 Filer 2011 - 2024
Protagonist Therapeutics, Inc
Patel Dinesh V Ph D
Gupta Suneel
Ali Asif
Selick Harold E
O'Dowd Sarah A
Molina Arturo MD
Giraudo Bryan
Williams Lewis T
Waddill William D.
Noonberg Sarah B.
Liu David Y
Kalkofen Donald A.
Saks Samuel R
Khosla Chaitan PhD
Shames Richard S.
Murphy Niall
O'Neil Thomas P.
Shanafelt Armen
Canaan Partners X LLC
Canaan X LP
Atchinson Robert
Gross Phillip
Adage Capital Advisors, L.L.C.
Adage Capital Partners, L.P.
Adage Capital Partners GP LLC
Grant Julie Papanek
Hodder William A
Johnson & Johnson Innovation - JJDC, Inc.
Johnson & Johnson
Lilly Ventures Fund I LLC
LV Management Group, LLC
Torres S. Edward
Hall Steven Edward
Form 13F Holdings
Firm Period DFND Voting Shares
RTW Investments LP [2023-03-31] SOLE 4,600,799.0 4,600,799.0
BlackRock Inc. [2023-03-31] SOLE 4,313,492.0 4,402,217.0
BVF Inc/IL [2023-03-31] DFND 0.0 3,775,900.0
Vanguard Group Inc [2023-03-31] SOLE 0.0 3,169,677.0
Farallon Capital Management LLC [2023-03-31] OTR 2,615,014.0 2,615,014.0
Adage Capital Partners GP LLC [2023-03-31] SOLE 2,558,000.0 2,558,000.0
Johnson & Johnson [2023-03-31] DFND 0.0 2,449,183.0
State Street Corp [2023-03-31] DFND 2,324,456.0 2,413,701.0
Cormorant Asset Management LP [2023-03-31] DFND 1,700,000.0 1,700,000.0
Citadel Advisors LLC [2023-03-31] DFND 1,646,480.0 1,646,480.0
Morgan Stanley [2023-03-31] DFND 1,559,750.0 1,570,510.0
Kynam Capital Management LP [2023-03-31] SOLE 1,375,000.0 1,375,000.0
Marshall Wace LLP [2023-03-31] OTR 0.0 1,366,080.0
Dimensional Fund Advisors LP [2023-03-31] SOLE 1,128,158.0 1,194,578.0
Millennium Management LLC [2023-03-31] SOLE 1,122,342.0 1,122,342.0
Perceptive Advisors LLC [2023-03-31] SOLE 965,152.0 965,152.0
Deutsche Bank AG [2023-03-31] DFND 52,130.0 958,891.0
Geode Capital Management LLC [2023-03-31] DFND 925,993.0 925,993.0
683 Capital Management LLC [2023-03-31] DFND 873,000.0 873,000.0
Susquehanna International Group LLP [2023-03-31] DFND 124,084.0 868,784.0
Nuveen Asset Management LLC [2023-03-31] DFND 828,471.0 828,471.0
Bank of America Corp /DE/ [2023-03-31] DFND 14,902.0 766,990.0
Renaissance Technologies LLC [2023-03-31] SOLE 690,867.0 690,867.0
Candriam SCA [2023-03-31] SOLE 625,000.0 625,000.0
Woodline Partners LP [2023-03-31] SOLE 618,615.0 618,615.0
Barclays PLC [2023-03-31] SOLE 583,737.0 583,737.0
Voloridge Investment Management LLC [2023-03-31] SOLE 465,323.0 465,323.0
Goldman Sachs Group Inc [2023-03-31] DFND 459,420.0 459,450.0
Two Sigma Advisers LP [2023-03-31] SOLE 377,600.0 449,800.0
Jennison Associates LLC [2023-03-31] DFND 428,938.0 428,938.0
Prev | Page 1 | Next
Terms | Privacy | Guide
tony@aum13f.com